Laman UtamaABUS • NASDAQ
add
Arbutus Biopharma Corp
Tutup sebelumnya
$4.50
Julat hari
$4.29 - $4.50
Julat tahun
$2.71 - $5.10
Permodalan pasaran
853.06J USD
Bilangan Purata
924.40K
Nisbah P/E
-
Hasil dividen
-
Pertukaran utama
NASDAQ
Berita pasaran
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (USD) | Jun 2025info | Perubahan T/T |
|---|---|---|
Hasil | 10.74J | 522.19% |
Perbelanjaan pengendalian | 8.45J | -61.55% |
Pendapatan bersih | 2.52J | 112.74% |
Margin untung bersih | 23.49 | 102.05% |
Pendapatan bagi setiap syer | 0.01 | 109.05% |
EBITDA | 1.92J | 109.15% |
Kadar cukai berkesan | — | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (USD) | Jun 2025info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 98.09J | -30.92% |
Jumlah aset | 103.27J | -35.48% |
Jumlah liabiliti | 20.29J | -46.02% |
Jumlah ekuiti | 82.98J | — |
Syer tertunggak | 191.70J | — |
Harga kepada buku | 10.47 | — |
Pulangan pada aset | 4.34% | — |
Pulangan pada modal | 5.54% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (USD) | Jun 2025info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | 2.52J | 112.74% |
Tunai daripada operasi | -15.75J | -8.58% |
Tunai daripada pelaburan | 15.61J | 58.83% |
Tunai daripada pembiayaan | 453.00K | -98.14% |
Perubahan bersih dalam tunai | 336.00K | -98.29% |
Aliran tunai bebas | -13.34J | -87.90% |
Perihal
Arbutus Biopharma Corporation is a publicly traded Canadian biopharmaceutical company with an expertise in liposomal drug delivery and RNA interference, and is developing drugs for hepatitis B infection.
It is headquartered in Warminster, Pennsylvania. The company was formerly known as Tekmira, which was spun out of Inex Pharmaceuticals in 2007. Wikipedia
Diasaskan
2007
Tapak web
Pekerja
44
